The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies.
about
Anticonvulsants for cocaine dependenceAnticonvulsants for alcohol dependenceAn evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) studyConcurrent validity of the Alcohol Use Disorders Identification Test (AUDIT) and AUDIT zones in defining levels of severity among out-patients with alcohol dependence in the COMBINE studyDim light melatonin onset in alcohol-dependent men and women compared with healthy controlsZonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disordersThe anticonvulsant zonisamide reduces ethanol self-administration by risky drinkersCue reactivity in active pathological, abstinent pathological, and regular gamblers.A meta-analysis of topiramate's effects for individuals with alcohol use disorders.The impacts of nitrous oxide gas on sleep quality during alcohol withdrawal.Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study.Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the NetherlandsMeasuring smoking-related preoccupation and compulsive drive: evaluation of the obsessive compulsive smoking scale.Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm--possible influence of self-control.A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.Varenicline effects on drinking, craving and neural reward processing among non-treatment-seeking alcohol-dependent individualsInvolvement of plasma atrial natriuretic peptide in protracted alcohol withdrawal.Predicting treatment seekers' readiness to change their drinking behavior in the COMBINE Study.Blood glucose level, alcohol heavy drinking, and alcohol craving during treatment for alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) Study.Human laboratory paradigms in alcohol research.Integrated care for comorbid alcohol dependence and anxiety and/or depressive disorder: study protocol for an assessor-blind, randomized controlled trialFunctional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review.Varenicline decreases alcohol consumption in heavy-drinking smokers.Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?Finding paradigms for the future of alcoholism research: an interdisciplinary perspective.Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.Assessing craving and its relationship to subsequent prescription opioid use among treatment-seeking prescription opioid dependent patientsStability of fMRI striatal response to alcohol cues: a hierarchical linear modeling approach.Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosateThe associations between self-consciousness, depressive state and craving to drink among alcohol dependent patients undergoing protracted withdrawalSleep homeostasis in alcohol-dependent, depressed and healthy control men.Moderating effects of a craving intervention on the relation between negative mood and heavy drinking following treatment for alcohol dependence.Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects.Social network moderators of naltrexone and behavioral treatment effects on heavy drinking in the COMBINE study.Predictive value of obsessive-compulsive drinking scale (OCDS) for outcome in alcohol-dependent inpatients: results of a 24-month follow-up study.The Obsessive Compulsive Cocaine Use Scale: development and initial validation of a self-rated instrument for the quantification of thoughts about cocaine use.Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependenceEffects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.Open label trial of the tolerability and efficacy of zonisamide in the treatment of alcohol dependence
P2860
Q24186475-1DBEDE25-8989-466C-8C39-A823CAB25DC0Q24200396-B9660FBB-0476-4FF8-96E2-747136775DF1Q24645469-68A1F6D9-97C5-4358-BE65-AAE603436BFCQ28277924-7AAC79D1-9410-4B66-AFF9-F33E5FE15022Q28383775-B04A1521-AFEB-465E-825F-BB8240C94229Q30611398-EF712C06-F406-42FD-8C8D-8B3FD5B7F696Q33637610-4D5E9867-5611-4DF2-8CB4-77E001F647AEQ33658418-B20D5361-3B9B-4DBE-B022-7519DB940485Q33717597-16C5669F-3717-4BF2-919B-1AD0684FEC48Q33864282-D954F4A7-9BCC-4061-9C00-94286E0D1192Q33930962-32EE3F8E-04F6-4EEC-A6D2-9DE869962F64Q33997733-7E7A0FCD-8AFE-42B2-BCA8-8CFF4E3B2C87Q34013383-901D9E48-9FEF-497E-9A96-C0315AE9AAF8Q34013720-EA8AA6C1-AC95-494C-8620-380CF0A07567Q34082918-E2E87AEC-C057-42FC-B038-46E6212BB5FCQ34097966-F002D3BD-E89B-444B-9FD5-875F49AC30E2Q34135604-89EB47FC-F254-4791-B66D-F6110B4630E1Q34195883-48A4F197-FE10-4617-BD39-5A8FF1BC9899Q34204342-86D3D8F6-8035-4AB8-A56F-3A86F406EE04Q34205530-AF3CF4E6-B545-4075-9D80-A5CDB315626DQ34245795-AF0CD2A6-F3E4-4CC3-A539-D7A7F83FFFBDQ34265274-E71BB118-9D1A-4A15-B484-8189D5276EF9Q34271996-767F60DA-89C4-4DAE-B511-F59559433F31Q34306652-1D02ED22-1C5B-42E6-A2B5-C5B46F0B2A52Q34389261-EBB02570-5229-4C40-B8A8-CD6E52BD3E56Q34622414-6E719041-A6EE-47C4-84B6-7D0BE751E08EQ34625628-6AD46F89-22F2-4ADB-B49E-48BAFDB26574Q34733307-DF206C42-3AAC-4ACD-ABE5-A5CDB9841A07Q34798686-5798C731-7F26-4198-8E2A-CBE6469FB649Q34980768-18F9FA83-1824-4CD8-B960-7E9EA151BF6AQ35167054-48CB3F98-0AAC-4DF3-B5E4-58B3A73E70C7Q35168364-E4FFA8CC-EF50-4921-AFBE-28438846B79FQ35243743-E805BBD5-831A-4861-906D-95E70E8D8357Q35565599-705E86B8-B7E0-40E2-AEB2-FD0634A299BBQ35574309-91D9B625-8466-4B7D-9412-9E2CE26D9A01Q35633126-B82DCB30-A16E-4D39-B0F3-9BD8CDAB25A2Q35760199-1BEAE30D-C3B0-4827-88E0-EE976D5C44B1Q35764036-47FBC0A3-4DB2-4685-BB25-4210DFAE2B46Q36150008-CB5978B7-FB0C-4C45-8097-59F2D23DE044Q36341608-D4DF017B-D0AD-4CF8-B7A6-DF69AE0727D3
P2860
The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
The obsessive compulsive drink ...... alcoholism treatment studies.
@en
The obsessive compulsive drink ...... alcoholism treatment studies.
@nl
type
label
The obsessive compulsive drink ...... alcoholism treatment studies.
@en
The obsessive compulsive drink ...... alcoholism treatment studies.
@nl
prefLabel
The obsessive compulsive drink ...... alcoholism treatment studies.
@en
The obsessive compulsive drink ...... alcoholism treatment studies.
@nl
P2093
P1433
P1476
The obsessive compulsive drink ...... alcoholism treatment studies.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1996.01830030047008
P407
P577
1996-03-01T00:00:00Z